Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is Volatility Shares 2x Sui ETF (SUIL) Up +17.52% Today?

Why Is Volatility Shares 2x Sui ETF (SUIL) Up +17.52% Today?

Key Takeaways

  • SUIL surged 17.52% to $12.68, up from a prior closing price of $10.79.
  • The primary catalyst was a sharp rally in the underlying Sui (SUI) token, amplified by the fund's 2x daily leverage.
  • SUI broke above its 200-day exponential moving average and reclaimed a key support zone, triggering a wave of short covering.
  • Concentrated short liquidations across major exchanges added fuel to the upside move.
  • A broader risk-on tone across the cryptocurrency market supported altcoin strength.
  • Investors are watching SUI's next technical levels and whether the momentum can be sustained.

Opening Summary

The Volatility Shares 2x Sui ETF (SUIL) tracks a leveraged daily investment objective of roughly two times the single-day performance of Sui (SUI), a layer-1 blockchain token. In today's session, SUIL rallied 17.52%, climbing to $12.68 from a prior close of $10.79, a gain of $1.89. The move was driven by a decisive breakout in the underlying SUI token, which advanced sharply amid a short squeeze and renewed bullish technical signals, with the ETF's 2x leverage magnifying that daily token move.

What Drove the ETF Move Today

Underlying Token Rally and Short Squeeze

The dominant driver behind SUIL's advance was the strength of its underlying asset. SUI climbed sharply during the session, with short positions worth hundreds of thousands of dollars liquidated across Binance, Bybit, and OKX. This concentrated short liquidation created a cascading squeeze, forcing bearish traders to buy back positions and accelerating the token's rise. Because SUIL seeks 2x daily exposure to SUI, this underlying move translated into a larger percentage gain for the ETF.

Technical Breakout Signals

The rally was reinforced by a bullish technical shift. SUI broke above its 200-day exponential moving average, a widely watched trend indicator, and reclaimed a key support zone that traders had been defending. Analysts also pointed to a bullish flip in the weekly Parabolic SAR indicator and a "buy" signal from the SuperTrend indicator, both of which are commonly interpreted as confirmation of a trend reversal. These signals drew momentum-oriented buyers into the token and, by extension, the leveraged ETF.

Network and Ecosystem Developments

Fundamental narrative also contributed to positive investor sentiment. Market commentators highlighted Sui's network improvements, including gasless stablecoin transfers and planned confidential payments, as factors supporting the token's longer-term payment use cases. This combination of technical breakout and ecosystem progress gave the rally a broader fundamental backdrop beyond pure short-covering.

Risk-On Sentiment and Leverage Amplification

The move unfolded against a constructive backdrop for altcoins, with SUI outperforming larger peers during the session. A risk-on tone across digital assets encouraged flows into higher-beta tokens, and leveraged products like SUIL captured outsized gains relative to the spot token as traders sought amplified exposure.

Which Holdings Contributed Most

SUIL does not hold a diversified basket of individual stocks. As a single-asset leveraged product, its performance is tied almost entirely to the daily movement of Sui (SUI) through derivative and swap-based exposure. Consequently, the entirety of today's move can be attributed to the underlying token's rally, rather than to the performance of any individual equity holding. The fund's 2x leverage target is the primary factor determining the magnitude of the daily return relative to SUI itself.

Market Context and Trading Activity

Trading activity in SUIL has been elevated in recent sessions as the underlying token regained momentum, with daily volume rising noticeably during the prior week's breakout. The ETF's move aligned with the broader uptrend in SUI and with a generally constructive session for altcoins, even as the move in SUI outpaced larger cryptocurrencies. The token's break above its 200-day moving average and the reclaiming of its support zone represented significant technical milestones that cleared the way for the day's advance. As a leveraged vehicle, SUIL tends to exhibit greater intraday volatility than the spot asset, and its price action reflected that amplification throughout the session.

What Comes Next for SUIL

Looking ahead, investors will monitor whether SUI can hold above its newly reclaimed support and sustain momentum toward subsequent resistance levels. Key factors to watch include the trajectory of short positioning and liquidation activity, overall cryptocurrency market sentiment, and any further network or ecosystem announcements from the Sui ecosystem. Macroeconomic conditions and risk appetite in broader financial markets will also influence altcoin flows. It is important to recognize the risks inherent in leveraged products: SUIL is designed for a daily 2x objective, and compounding over multiple sessions can cause returns to diverge significantly from two times the longer-term performance of SUI, particularly in volatile or choppy markets. The same leverage that amplified today's gain can magnify losses if the underlying token reverses.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a range of approaches to explore. If you're looking for data-driven tools to help navigate fast-moving markets, consider reviewing the Trending AI Robots to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SUIL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of SUI. The fund does not seek to achieve its stated investment objective over a period of time greater than a single day. Under normal circumstances, the fund will invest at least 80% of the value of its net assets (plus borrowings for investment purposes) in SUI-Linked Instruments. SUI is a digital commodity that is emitted and transmitted through the operations of the delegated proof-of-stake Sui Network, a decentralized network of computers that operates on cryptographic protocols. It is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Miscellaneous
Address
Volatility Shares Trust2000 PGA Blvd, Suite 4400
Phone
N/A
Web
N/A
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Why Is Volatility Shares 2x Sui ETF (SUIL) Up +17.52% Today?